Metaverse Surgical Simulation Platform
Metaverse
1 other identifier
observational
70
1 country
1
Brief Summary
This project aims to combine virtual reality (VR) technologies to construct a metaverse simulation lung surgery platform, which can not only be used as equipment for training novices, but also as a simulated rehearsal before actual surgery, to improve the safety and smoothness of difficult surgeries.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Jan 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedFirst Submitted
Initial submission to the registry
July 16, 2024
CompletedFirst Posted
Study publicly available on registry
July 22, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2024
CompletedJuly 24, 2024
July 1, 2024
10 months
July 16, 2024
July 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
questionnaires
To evaluate the satisfaction levels of students or operators
Through study completion, an average of 1 year.
Study Arms (1)
Virtual reality surgery
The investigators have completed the translation of personalized 3D models from CT images into virtual 3D models displayed on VR glasses using Synapse (Fujifilm). Additionally, the investigators can illustrate reference CT scans, chart summaries, laboratory data, and other medical information within the VR environment.
Interventions
The investigators have finished is personalized 3D model translation from CT images into virtual 3D model demonstrated in VR glasses using Synapse.
Eligibility Criteria
Patients diagnosed by surgeons with the following conditions will be included in the eligible group: 1. Complex thoracic surgery, 2. Large mediastinal tumors, 3. Interpulmonary tumors, 4. Patients requiring tracheal transplantation.
You may qualify if:
- Physicians assess suitable candidates.
- Consent to the use of their high-resolution computed tomography (CT) scan results as digital simulation material for the establishment of a virtual reality surgical platform.
You may not qualify if:
- Those without high-resolution computed tomography (CT) scan results.
- Any conditions and circumstances that the trial principal investigator believes may affect the establishment of the trial platform.
- Those who have concerns about providing their own CT data.
- (1) Individuals under the age of 18 are excluded.
- (2) Any condition or circumstance that the principal investigator deems may affect the establishment of the trial platform.
- (3) Those who have concerns about providing their own data related to using the surgical simulation platform.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Surgery, National Taiwain University Hospital
Taipei, 100, Taiwan
Study Officials
- PRINCIPAL INVESTIGATOR
Xu-Heng Chiang, MD
National Taiwan University Hospital
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 16, 2024
First Posted
July 22, 2024
Study Start
January 1, 2024
Primary Completion
October 30, 2024
Study Completion
December 31, 2024
Last Updated
July 24, 2024
Record last verified: 2024-07